In vivo experimental study on bone regeneration in critical bone defects using PIB nanogels/boron-containing mesoporous bioactive glass composite scaffold

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 839-846

  Chen, Xiaohui ^a,b   Zhao, Yanbing ^c   Geng, Shinan ^c   Miron, Richard J ^a   Zhang, Qiao ^a   Wu, Chengtie ^d   Zhang, Yufeng ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Wuhan University   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Bone graft; Boron; Mesoporous bioactive graft; Osteoporosis; Osteoporotic defect; Tissue engineering

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOMATERIAL; BORON; COPOLYMER; EOSIN; GLASS; HEMATOXYLIN; MOLECULAR SCAFFOLD; N ISOPROPYLACRYLAMIDE BUTYL METHACRYLATE COPOLYMER; NANOGLASS; NANOMATERIAL; UNCLASSIFIED DRUG; ACID PHOSPHATASE; ACRYLIC ACID DERIVATIVE; ISOENZYME; MACROGOL DERIVATIVE; NANOGEL; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BODY TEMPERATURE; BONE DEFECT; BONE REGENERATION; BONE REMODELING; BONE STRENGTH; BONE TRANSPLANTATION; EXPERIMENTAL STUDY; FEMALE; FEMUR DEFECT; GELATION; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARIECTOMY; POROSITY; RAT; TIME; TISSUE ENGINEERING; TREATMENT OUTCOME; ANIMAL; BONE DEVELOPMENT; CHEMISTRY; FEMUR; INJURIES; METABOLISM; PATHOLOGY; PHYSIOLOGY; TISSUE SCAFFOLD; WISTAR RAT;

LAKE VICTORIA MARBURGVIRUS; RATTUS;

ACID PHOSPHATASE; ACRYLATES; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; BORON; FEMALE; FEMUR; GLASS; ISOENZYMES; OSTEOGENESIS; OVARIECTOMY; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; POROSITY; RATS; RATS, WISTAR; TARTRATE-RESISTANT ACID PHOSPHATASE; TISSUE SCAFFOLDS;

EID: 84921886810     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S69001     Document Type: Article

References (37)

1. Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10(4):259–264.
2. Roush K. Prevention and treatment of osteoporosis in postmenopausal women: a review. Am J Nurs. 2011;111(8):26–35.
3. Seeman E, Eisman JA. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual’s absolute risk of fracture. Med J Aust. 2004;180(6):298–303.
4. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633–1650.
5. Silva BC, Bilezikian JP. New approaches to the treatment of osteoporosis. Annu Rev Med. 2011;62:307-322.
6. Becker DJ, Kilgore ML, Morrisey MA. The societal burden of osteoporosis. Curr Rheumatol Rep. 2010;12(3):186-191.
7. Li X, Shi J, Dong X, Zhang L, Zeng H. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior. J Biomed Mater Res A. 2008;84(1):84-91.
8. Mondrinos MJ, Dembzynski R, Lu L, et al. Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineering. Biomaterials. 2006;27(25):4399-4408.
9. Wu C, Miron R, Sculean A, et al. Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. Biomaterials. 2011;32(29):7068-7078.
10. Zhang Y, Cheng N, Miron R, Shi B, Cheng X. Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects. Biomaterials. 2012;33(28):6698-6708.
11. Gorustovich AA, Lopez JM, Guglielmotti MB, Cabrini RL. Biological performance of boron-modified bioactive glass particles implanted in rat tibia bone marrow. Biomed Mater. 2006;1(3):100-105.
12. Miron RJ, Zhang YF. Osteoinduction: a review of old concepts with new standards. J Dent Res. 2012;91(8):736-744.
13. Yun HS, Kim SE, Hyun YT, Heo SJ, Shin JW. Hierarchically mesoporous-macroporous bioactive glasses scaffolds for bone tissue regeneration. J Biomed Mater Res B Appl Biomater. 2008;87(2):374-380.
14. Wu C, Luo Y, Cuniberti G, Xiao Y, Gelinsky M. Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater. 2011;7(6):2644-2650.
15. Zhao H, Zheng C, Feng G, et al. Temperature-Sensitive poly(N-Isopropylacrylamide-Co-Butyl Methylacrylate) Nanogel as an Embolic Agent: Distribution, Durability of Vascular Occlusion, and Inflammatory Reactions in the Renal Artery of Rabbits. AJNR Am J Neuroradiol. 2013;34(1):169-176.
16. Dong Y, Saeed AO, Hassan W, et al. “One-step” Preparation of Thiol-Ene Clickable PEG-Based Thermoresponsive Hyperbranched Copolymer for In Situ Crosslinking Hybrid Hydrogel. Macromol Rapid Commun. Epub 2011 Dec 5.
17. Zhao Y, Zheng C, Wang Q, et al. Permanent and Peripheral Embolization: Temperature-Sensitive p(N-Isopropylacrylamide-co-butyl Methylacrylate) Nanogel as a Novel Blood-Vessel-Embolic Material in the Interventional Therapy of Liver Tumors. Advanced Functional Materials. 2011;21(11):2035-2042.
18. Cheng N, Dai J, Cheng X, et al. Porous CaP/silk composite scaffolds to repair femur defects in an osteoporotic model. J Mater Sci Mater Med. 2013;24(8):1963-1975.
19. Wei L, Ke J, Prasadam I, et al. A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects. Osteoporosis Int. 2014;25(8):2089-2096.
20. Zhang Y, Wu C, Luo T, Li S, Cheng X, Miron RJ. Synthesis and inflammatory response of a novel silk fibroin scaffold containing BMP7 adenovirus for bone regeneration. Bone. 2012;51(4):704-713.
21. Miron RJ, Wei L, Bosshardt DD, Buser D, Sculean A, Zhang Y. Effects of enamel matrix proteins in combination with a bovine-derived natural bone mineral for the repair of bone defects. Clin Oral Investig. 2014;18(2):471-478.
22. Fernandes JC, Wang H, Jreyssaty C, et al. Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. Mol Ther. 2008;16(7):1243-1251.
23. Wang L, Fan H, Zhang ZY, et al. Osteogenesis and angiogenesis of tissue-engineered bone constructed by prevascularized beta-tricalcium phosphate scaffold and mesenchymal stem cells. Biomaterials. 2010;31(36):9452-9461.
24. Yang S, Lan L, Miron RJ, Wei L, Zhang M, Zhang Y. Variability in Particle Degradation of Four Commonly Employed Dental Bone Grafts. Clin Implant Dent Relat Res. Epub 2014 Jan 3.
25. Saulacic N, Bosshardt DD, Jensen SS, Miron RJ, Gruber R, Buser D. Impact of bone graft harvesting techniques on bone formation and graft resorption: a histomorphometric study in the mandibles of minipigs. Clin Oral Implants Res. Epub 2014 Feb 19.
26. Kim J, Kim IS, Cho TH, et al. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials. 2007;28(10):1830-1837.
27. Park KH, Kim H, Moon S, Na K. Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering. J Biosci Bioeng. 2009; 108(6):530-537.
28. Kang SW, Kim JS, Park KS, et al. Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration. Bone. 2011;48(2): 298-306.
29. Hayashi C, Hasegawa U, Saita Y, et al. Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor. J Cell Physiol. 2009;220(1):1-7.
30. Li SH, De Wijn JR, Layrolle P, de Groot K. Synthesis of macroporous hydroxyapatite scaffolds for bone tissue engineering. J Biomed Mater Res. 2002;61(1):109-120.
31. Zhang R, Ma PX. Poly(a-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res. 1999;44(4):446-455.
32. Tsigkou O, Hench LL, Boccaccini AR, Polak JM, Stevens MM. Enhanced differentiation and mineralization of human fetal osteoblasts on PDLLA containing Bioglass composite films in the absence of osteogenic supplements. J Biomed Mater Res A. 2007;80(4):837-851.
33. Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. J Control Release. 2007;119(1): 5-24.
34. Zhou Z, Yang D, Nie J, Ren Y, Cui F. Injectable Poly(ethylene glycol) Dimethacrylate-based Hydrogels with Hydroxyapatite. Journal of Bioactive and Compatible Polymers. 2009;24(5):405-423.
35. Wu C, Zhang Y, Zhu Y, Friis T, Xiao Y. Structure-property relationships of silk-modified mesoporous bioglass scaffolds. Biomaterials. 2010; 31(13):3429-3438.
36. Lopez-Noriega A, Arcos D, Izquierdo-Barba I, Sakamoto Y, Terasaki O, Vallet-Regi M. Ordered Mesoporous Bioactive Glasses for Bone Tissue Regeneration. Chem Mater. 2006;18(13):3137-3144.
37. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006;27(18):3413-3431.